StonvexLoading…
StonvexStonvexStonvexCore line items from OXM's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2026 2026-01-31 | Annual 2025 2025-02-01 | Annual 2024 2024-02-03 | Annual 2023 2023-01-28 |
|---|---|---|---|---|
Revenue | $1.48B | $1.52B | $1.57B | $1.41B |
Operating Income | $-31.28M | $119.04M | $80.98M | $218.77M |
Net Income | $-27.89M | $92.97M | $60.70M | $165.74M |
EPS (Diluted) | $-1.86 | $5.87 | $3.82 | $10.19 |
Total Assets | $1.31B | $1.29B | $1.10B | $1.19B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $8.13M | $9.47M | $7.60M | $8.83M |
Free Cash Flow OCF − CapEx | $11.31M | $59.80M | $170.19M | $78.94M |
Shares Outstanding | 15.00M | 16.00M | 16.00M | 16.00M |